Since the United States announced in 2015 the precise medical plan, precise medical quickly become the focus of the global medical community debate and concern. At present, the global market for precision medical care has exceeded $60 billion, 2015-2020 growth of up to 15% during the period, the pharmaceutical industry as a whole growth rate of 3 to 4 times. As a sponsor of the United States, with highly developed health care industry to promote innovation in medical technology, precision medical project at the beginning, the U.S. government will invest $215 million. Chinese as one of the main force to promote medical precision, increase the precision of medical support: precise medical plan has been included in the national major special "13th Five-Year" science and technology development, national strategy; Ministry of science and technology in 2030 plans to invest 60 billion yuan to promote the industry development.
Favorable policy environment, the favor of the capital market, the innovation of medical science and technology to bring new opportunities for the development of precision medical industry. However, where is the way out of precision medical industrialization? How to combine big data with precision? What are the current status and challenges in the field of gene detection, precision diagnosis and targeted drugs? How to enter the hospital precision medical construction? What is the current status of clinical research and development of precision therapy? The conference will invite 800+ from the government regulatory agencies, industry associations, Sino US hospitals, pharmaceutical companies, research institutions, life science and Biotech Corp, CRO enterprises, big data solutions provider, investment institutions, law firms, consulting institutions and other senior representatives to discuss the opportunities and challenges in the precise medical beauty, boost bilateral precise medical industry development. The world's two largest economy, the industry elite how to wipe out what kind of spark? The organizing committee is looking forward to your participation!
DAI Tao
Deputy Director
Development Center for Medical Science and Technology National Health and Family Planing Commission of the People's Republic of China
Dr. Lane Christensen
Deputy Director
FDA China’s Office
Dr. ZHAN Qimin
Director
Peking University Health Science Center
Dr. NING Guang(Invited)
Vice-President
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine
GianLuca Pettiti
President China
Thermo Fisher Scientific
Dr. Stacy W. Gray(Invited)
Associate Professor
City of Hope National Medical Center
Dr. Stephne Bonree
Chief Scientist
Beijing Lawke Health Laboratory Center for Clinical Laboratory Development
Dr. ZHU Jianwei
President
Shanghai Jiao Tong University (SJTU) School of Pharmacy
Dr. GAO Weiqiang
President
Shanghai Jiao Tong University (SJTU) School of Biomedical
Dr. XU Qiang
CEO
Genomicare
Dr. ZHANG Qin
Vice-President
Jiangsu Cancer Hospital
Prof. AI Huisheng
Director
Hematology Department of 307 Hospital of Beijing
Dr. QIAN Qijun
President
Shanghai Cell Therapy Research Institute
Dr. ZHOU Caicun
Director
Shanghai Pulmonary Hospital Oncology Department
Dr. XIA Jianchuan
Director
Biotherapy Center of Sun Yat-sen University Cancer Center
Dr. ZHAN Xianbao
Director
Shanghai Changhai Hospital Oncology Department
Dr. ZHAN Xianquan
Director
State Key Laboratory of Tumor Protein,Xiangya Hospital
Dr. QIN Jun
Director
Beijing Proteome Research Center
Dr. SHU Yongqian
Director
Jiangsu Province Hospital Oncology Department
Dr. LIU Lei
Professor
Fudan University
Dr. CHEN Luonan
Professor
Shanghai Institutes for Biological Sciences
Dr. BAO Yiming
Director of Center for Life and Health
Genomics Institute, Chinese Academy of Sciences
Dr. WU Jianmin
Director
Beijing Cancer Hospital Bioinformatics Center
Dr. LV Hui
Director
Children’s Hospital of Shanghai Bio-information Department
Dr. QI Ming
Professor
Zhejiang University
Dr. ZHANG Bo
Director
Peking University Third Hospital Pathology Department
Dr. SHEN Lisong
Director
Shanghai Xinhua Hospital Clinical Laboratory Department
Dr. LOU Jiatou
Director
Shanghai Chest Hospital Clinical Laboratory Department
18521034370
+8621 68407631*8039
pmf@cdmc.org.cn
Tety Zhang
官方微信号